| Structure |
Chemical Name |
CAS |
MF |
 |
(E)-2-CYANO-5-METHYL-HEX-2-ENOIC ACID METHYL ESTER |
96914-67-9 |
C9H13NO2 |
 |
Olodaterol Impurity 33 |
|
|
 |
(E)-3-(2-Formylphenyl)-2-propenoic acid 1,1-dimethyl ethyl ester |
103890-69-3 |
C14H16O3 |
 |
(R)-N-((S)-1-amino-1-oxobutan-2-yl)-3-((((S)-1-amino-1-oxobutan-2-yl)amino)methyl)hexanamide |
|
C15H30N4O3 |
 |
Tamsulosin impurity |
1429436-97-4 |
C20H28N2O5S |
 |
Abiraterone Impurity 4 |
2118-32-3 |
C23H34O2 |
 |
Rifaximin impurity B |
1351775-04-6 |
C43H49N3O11 |
 |
(R)-テラゾシン |
109351-34-0 |
C19H25N5O4 |
 |
2-クロロ-N-(2,5-ジメチルフェニル)アセトアミド |
5177-35-5 |
C10H12ClNO |
 |
Ertapenem Impurity C(USP) |
|
|
 |
2-(クロロメチル)-3-メチル-4-(2,2,2-トリフルオロエトキシ)ピリジン |
128430-66-0 |
C9H9ClF3NO |
 |
Sulpiride Impurity 4 |
|
|
 |
Tofacitinib Impurity 103 |
|
|
 |
Atracurium Impurity 4 |
|
|
 |
Adefovir Impurity 2 |
|
|
 |
Nintedanib Impurity L |
2095596-44-2 |
C31H33N5O4 |
 |
(R)-3-AMINO-4-(2,4-DIFLUOROPHENYL)-BUTYRIC ACID-HCL |
1335470-16-0 |
C10H11F2NO2 |
 |
Tirofiban hydrochloride Impurity 6 |
2250244-31-4 |
C17H27NO7S2 |
 |
(R)-3-((S)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one |
404874-94-8 |
C20H20FNO4 |
 |
Azithromycin EP Impurity K |
|
|
 |
Palbociclib Impurity 2 |
|
|
 |
Rocuronium Bromide Impurity 25 |
|
|
 |
Erlotinib Impurity 37 |
|
|
 |
Gatifloxacinacid |
121577-32-0 |
C19H22FN3O4.ClH |
 |
SofosBuvir Impurity 52 |
|
|
 |
(3R)-3-フェニル-β-アラニン |
13921-90-9 |
C9H11NO2 |
 |
Fluconazole IMpurity D |
|
C13H12F2N6O |
 |
Clarithromycin Impurity EP G |
107216-09-1 |
C39H72N2O13 |
 |
Rosuvastatin Impurity 118 |
|
|
 |
Saxagliptin IMpurity 1 |
1564266-73-4 |
C6H10N2O |
 |
Adefovir Impurity 6 |
|
|
![Benzenepropanoic acid, 2,4-dichloro-α-[(dimethylamino)methylene]-3-methyl-β-oxo-, ethyl ester](/CAS/20211123/GIF/2241304-69-6.gif) |
Benzenepropanoic acid, 2,4-dichloro-α-[(dimethylamino)methylene]-3-methyl-β-oxo-, ethyl ester |
2241304-69-6 |
C15H17Cl2NO3 |
 |
Sitagliptin EP Impurity 6 |
|
|
 |
(S)-N,N-dimethyl-3-((R)-3-(naphthalen-1-yloxy)-1-phenylpropoxy)-1-phenylpropan-1-amine |
|
C30H33NO2 |
 |
Vildagliptin Impurity 39 |
|
|
 |
Clindamycin Impurity 86 |
|
|
 |
Pitavastatin Impurity 52 |
|
|
 |
Aprepitant impurity 4 |
|
|
 |
1H-1,2,4-Triazole-1-ethanol, α-(2,4-difluorophenyl)-α-(1H-1,2,4-triazol-1-ylmethyl)-, 4-oxide |
1997296-62-4 |
C13H12F2N6O2 |
![6-((S)-7-amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-7-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid](/) |
6-((S)-7-amino-5-azaspiro[2.4]heptan-5-yl)-8-chloro-7-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
|
|
 |
1-(chloromethyl)-2-trifluoromethyl-4-methylbenzene |
1261456-37-4 |
C9H8ClF3 |
 |
Bendamustine Impurity 15 |
|
|
 |
Solifenacin Related CoMpound 4 Succinate |
862207-71-4 |
C27H32N2O6 |
 |
Lenvatinib Impurity 38 |
|
|
 |
Sitagliptin Carbamoyl -D-Glucuronide |
940002-59-5 |
C23H23F6N5O9 |
 |
Trifluridine Impurity |
2086328-10-9 |
C10H11F3N2O5 |
![AMOXICILLIN TRIHYDRATE IMP. E (EP): (2RS,4S)-2-[[[(2R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETYL]AMINO]METHYL]-5,5-DIMETHYLTHIAZOLIDINE-4-CARBOXYLIC ACID (PENILLOIC ACIDS OF AMOXICILLIN)](/) |
AMOXICILLIN TRIHYDRATE IMP. E (EP): (2RS,4S)-2-[[[(2R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETYL]AMINO]METHYL]-5,5-DIMETHYLTHIAZOLIDINE-4-CARBOXYLIC ACID (PENILLOIC ACIDS OF AMOXICILLIN) |
|
|
 |
Moxifloxacin Impurity 67 |
1430075-14-1 |
C10H16ClNO3 |
 |
mixture of PD 312236 and PD 312237 |
|
|
 |
Fosaprepitant iMpurity |
|
|
 |
((2R,3S,4R)-3,4,5-trihydroxytetrahydrofuran-2-yl)methyl isobutyrate |
2591381-21-2 |
C9H16O6 |
 |
Vonoprazan Impurity 4 |
|
|
![4-amino-5-ethylsulfonyl-2-methoxy-N-[[1-(1,1,2,2,2-pentadeuterioethyl)pyrrolidin-2-yl]methyl]benzamide](/CAS/20180528/GIF/1216626-17-3.gif) |
4-amino-5-ethylsulfonyl-2-methoxy-N-[[1-(1,1,2,2,2-pentadeuterioethyl)pyrrolidin-2-yl]methyl]benzamide |
1216626-17-3 |
C17H22D5N3O4S |
 |
アジスロマイシンB |
307974-61-4 |
C38H72N2O11 |
 |
Rosuvastatin Impurity 119 |
|
|
 |
Edaravone Impurity P4 |
|
|
 |
L-Cefadroxil Impurity F(EP) |
|
|
 |
Sugammadex sodium Impurity 50 |
|
|
 |
Rosuvastatin Impurity 149 |
|
|
 |
Lenvatinib Impurity 17 |
|
|
 |
Urapidil Impurity 17 |
|
|
 |
Cefathiamidine Impurity G |
|
|
 |
Ticagrelor Impurity 10 |
|
|
 |
Mirabegron Impurity 8 HCl |
1684452-81-0 |
C21H24N4O2S |
 |
Pentanamide, 5-(diphenylphosphinyl)-N-ethyl- |
2512198-63-7 |
C19H24NO2P |
 |
Sugammadex sodium Hepta-Iodine Impurity |
|
|
 |
Palbociclib Impurity 39 |
|
|
 |
Dehydrocarteolol Hydrochloride |
62330-84-1 |
C16H22N2O3 |
 |
N-(2-ヒドロキシエチル)-4-ピリジンカルボアミド |
6265-74-3 |
C8H10N2O2 |
 |
1-((2'-cyanobiphenyl-4-yl)Methyl)-2-ethoxy-1H-benziMidazole-7-carboxylic acid |
632322-61-3 |
C24H19N3O3 |
 |
Furosemide Impurity 3 |
|
C12H11ClN2O5S |
 |
Trelagliptin Impurity isomer |
2206135-35-3 |
C18H20FN5O2 |
 |
Emtricitabine Ring-opening Impurity |
|
|
 |
デカルボキシエンロフロキサシン |
131775-99-0 |
C18H22FN3O |
 |
Atomoxetine impurity |
42064-62-0 |
C18H24ClNO |
 |
Urapidil Impurity |
770-42-3 |
C8H9BrFN.BrH |
 |
Tigecycline Impurity 2 |
1422262-97-2 |
C29H39N5O8 |
 |
Prasugrel Impurity 10 |
|
|
 |
Sugammadex sodium Org199074-1 Impurity |
|
|
 |
Acyclovir Impurity 11 |
|
|
 |
Trelagliptin Impurity 23 |
|
|
 |
Sitagliptin EP Impurity 7 |
|
|
![2-[[[3-メチル-4-(2,2,2-トリフルオロエトキシ)-2-ピリジニル]メチル]スルフィニル]-1H-ベンゾイミダゾール-5-オール](/CAS/GIF/131926-98-2.gif) |
2-[[[3-メチル-4-(2,2,2-トリフルオロエトキシ)-2-ピリジニル]メチル]スルフィニル]-1H-ベンゾイミダゾール-5-オール |
131926-98-2 |
C16H14F3N3O3S |
 |
Olaparib Impurity 58 |
848136-41-4 |
C22H21FN4O3 |
 |
Empagliflozin Furanose Impurity |
|
|
 |
3-((methoxycarbonyl)methyl)-5-methylhexanoic acid |
181289-11-2 |
C10H18O4 |
 |
Sugammadex sodium Org238832-1 Impurity |
|
|
 |
Eliglustat Impurity 2(Eliglustat SR-Isomer) |
1092472-66-6 |
C23H36N2O4 |
![Budesonide Related Compound E (16alpha,17-[butylidenebis(oxy)]-11Beta,21-dihydroxypregna-1,4,14-triene-3,20-dione)](/CAS/GIF/131918-64-4.gif) |
Budesonide Related Compound E (16alpha,17-[butylidenebis(oxy)]-11Beta,21-dihydroxypregna-1,4,14-triene-3,20-dione) |
131918-64-4 |
C25H32O6 |
 |
Pemetrexed disodium Impurity 32 |
|
|
![Sulfamide, N-[5-(4-bromophenyl)-6-[2-[(5-chloro-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propyl-](/CAS/20210305/GIF/2443747-63-3.gif) |
Sulfamide, N-[5-(4-bromophenyl)-6-[2-[(5-chloro-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propyl- |
2443747-63-3 |
C19H20BrClN6O4S |
 |
Dofetilide Impurity A |
|
|
 |
Cabozantinib impurity D |
|
|
![Acetamide, N-?[4-?[5-?(acetylamino)?-?2-?hydroxyphenoxy]?phenyl]?-](/CAS/20211123/GIF/2575516-61-7.gif) |
Acetamide, N-?[4-?[5-?(acetylamino)?-?2-?hydroxyphenoxy]?phenyl]?- |
2575516-61-7 |
C16H16N2O4 |
 |
Lamivudine impurity |
|
|
 |
Crisaborole intermediate |
2354382-27-5 |
C14H8BCl2NO3 |
 |
Ipragliflozin IMP |
|
|
 |
Oseltamivir Impurity 66 |
|
|
 |
2-Pyridinecarbonitrile, 5-isocyanato-3-(trifluoromethyl)- |
1950587-21-9 |
C8H2F3N3O |
 |
2,3‐デヒドロシリビンB |
142796-24-5 |
C25H20O10 |